Antyhypertensive effect of felodipine after kidney transplantation
Abstract
About the Authors
O. N. KotenkoRussian Federation
A. R. Bagdasaryan
Russian Federation
References
1. Ким И.Г., Стенина И.И., Ильинский И.И., Томилина Н.А. Отдаленные результаты трансплантации почки и факторы риска хронической нефропатии отторжения. Нефрология и диализ 1999; 1; 1: 27-38.
2. Сидоренко Б.А., Преображенский Д.В. Антагонисты кальция. -М., 1997.
3. Aakhus S., Dahl K., Wider∅e T.E. Cardiovascular morbidity and risk factors in renal transplant patients Nephrol. Dial. Transplant. 1999; 14: 648-654.
4. Batiuk T.D. et al. Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients. Transplantation 1995; 59; 10: 1400-1404.
5. Curtis J.J. Treatment of hypertension in renal allograft patients: Does drug selection make a difference? Kidney Int. 1997;52; Suppl. 63: S-75-S-77.
6. First M.R. et al. Hypertension after renal transplantation. J.Am.Soc. Nephrol 1994; 4 (Suppl 1) S30.
7. Guidi E. et al. Hypertension may be transplanted with the kidney in humans: A long-term historical perspective follow-up of recipients grafted with kidneys coming from donors with or without hypertension in their families. J Am Soc Nephrol 1996; 7:1131.
8. Hricik D.E. et al. Variable effects of steroid withdrawl on blood pressure reduction in cyclosporine treated renal transplant recipients. Transplantation 1992; 53:1232.
9. Kahan B.D. Drug therapy: Cyclosporine. N. Engl. J. Med. 1989; 321:1725.
10. Kaplan N.M. Clinical Hypertension 1998; 181-273.
11. Ljung B. Vascularselectivity of felodipine. Drugs 1985; 29 Suppl., 2:46-58.
12. Madsen J.K., Kornerup H.J., Pedersen E.B. Effect of felodipine on renal haemodynamics and tubular sodium handling after single-dose cyclosporin infusion in renal transplant recipients treated with azathioprine and prednisolone. Scand. J. Clin. Lab. Invest. 1995; 55; 625-623.
13. Porter G.A., Bennet W.M., Sheps S.G. Cyclosporine-associated hypertension. Arch. Intern. Med. 1990; 150:280.
14. Qiu C. et al. Endothelin and angiotensin mediate most glomerular responses to nitric oxide inhibition Kidney Int., 1999; 55: 2390-2396.
15. Ruggenenti P., Perico N., Mosconi L. et al. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int. 1993; 43:706.
16. Sanders C.E. and J.J. Curtis. Role of hypertension in renal allograft dysfunction. Kidney Int. 1995; 48: (Suppl.52) 43-47.
17. Scholz H. Pharmacologic aspects of calcium channel blockers. Cardiovascul Drugs Therapy, 1997; 10: 869 - 72.
18. Strom T.V. and Suthanthriran M. Therapeutic approach to renal transplantation. In: Davison A.M., Cameron J.S., Grufeld J-P et al. Eds. Oxford Textbook of Clinical Nephrology, Oxford University Press, Oxford, New York, Tokyo 1998; 2147-2151.
19. Sun J. et al. Calcium channel antagonists: cardiovascular selectivity of action. J.Pharmacol. Exp. Ther. 1995; 9:657-63.
Review
For citations:
Kotenko O.N., Bagdasaryan A.R. Antyhypertensive effect of felodipine after kidney transplantation. Nephrology and Dialysis. 1999;1(2-3):150-155. (In Russ.)